226 related articles for article (PubMed ID: 23088757)
1. The skin surface as antimicrobial barrier: present concepts and future outlooks.
Harder J; Schröder JM; Gläser R
Exp Dermatol; 2013 Jan; 22(1):1-5. PubMed ID: 23088757
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial peptides in human skin.
Harder J; Schröder JM
Chem Immunol Allergy; 2005; 86():22-41. PubMed ID: 15976486
[TBL] [Abstract][Full Text] [Related]
3. Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases.
Niyonsaba F; Kiatsurayanon C; Chieosilapatham P; Ogawa H
Exp Dermatol; 2017 Nov; 26(11):989-998. PubMed ID: 28191680
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of antimicrobial peptides in psoriasis and psoriatic arthritis as a novel contributory mechanism for skin and joint disease heterogeneity.
Bierkarre H; Harder J; Cuthbert R; Emery P; Leuschner I; Mrowietz U; Hedderich J; McGonagle D; Gläser R
Scand J Rheumatol; 2016; 45(3):188-96. PubMed ID: 26599663
[TBL] [Abstract][Full Text] [Related]
5. Visfatin enhances the production of cathelicidin antimicrobial peptide, human β-defensin-2, human β-defensin-3, and S100A7 in human keratinocytes and their orthologs in murine imiquimod-induced psoriatic skin.
Hau CS; Kanda N; Noda S; Tatsuta A; Kamata M; Shibata S; Asano Y; Sato S; Watanabe S; Tada Y
Am J Pathol; 2013 May; 182(5):1705-17. PubMed ID: 23499548
[TBL] [Abstract][Full Text] [Related]
6. The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption.
Gläser R; Meyer-Hoffert U; Harder J; Cordes J; Wittersheim M; Kobliakova J; Fölster-Holst R; Proksch E; Schröder JM; Schwarz T
J Invest Dermatol; 2009 Mar; 129(3):641-9. PubMed ID: 18754038
[TBL] [Abstract][Full Text] [Related]
7. What is really in control of skin immunity: lymphocytes, dendritic cells, or keratinocytes? facts and controversies.
Rupec RA; Boneberger S; Ruzicka T
Clin Dermatol; 2010; 28(1):62-6. PubMed ID: 20082953
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial peptides: effectors of innate immunity in the skin.
Barak O; Treat JR; James WD
Adv Dermatol; 2005; 21():357-74. PubMed ID: 16350450
[TBL] [Abstract][Full Text] [Related]
9. Significant upregulation of antimicrobial peptides and proteins in lichen sclerosus.
Gambichler T; Skrygan M; Tigges C; Kobus S; Gläser R; Kreuter A
Br J Dermatol; 2009 Nov; 161(5):1136-42. PubMed ID: 19558556
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial skin peptides and proteins.
Schröder JM; Harder J
Cell Mol Life Sci; 2006 Feb; 63(4):469-86. PubMed ID: 16416029
[TBL] [Abstract][Full Text] [Related]
11. Differential expression and in vivo secretion of the antimicrobial peptides psoriasin (S100A7), RNase 7, human beta-defensin-2 and -3 in healthy human skin.
Wittersheim M; Cordes J; Meyer-Hoffert U; Harder J; Hedderich J; Gläser R
Exp Dermatol; 2013 May; 22(5):364-6. PubMed ID: 23614747
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury.
Harder J; Dressel S; Wittersheim M; Cordes J; Meyer-Hoffert U; Mrowietz U; Fölster-Holst R; Proksch E; Schröder JM; Schwarz T; Gläser R
J Invest Dermatol; 2010 May; 130(5):1355-64. PubMed ID: 20107483
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-36 cytokines enhance the production of host defense peptides psoriasin and LL-37 by human keratinocytes through activation of MAPKs and NF-κB.
Nguyen TT; Niyonsaba F; Ushio H; Akiyama T; Kiatsurayanon C; Smithrithee R; Ikeda S; Okumura K; Ogawa H
J Dermatol Sci; 2012 Oct; 68(1):63-6. PubMed ID: 22901663
[No Abstract] [Full Text] [Related]
14. Differential expression pattern of antimicrobial peptides in nasal mucosa and secretion.
Laudien M; Dressel S; Harder J; Gläser R
Rhinology; 2011 Mar; 49(1):107-11. PubMed ID: 21468384
[TBL] [Abstract][Full Text] [Related]
15. Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense.
Murakami M; Lopez-Garcia B; Braff M; Dorschner RA; Gallo RL
J Immunol; 2004 Mar; 172(5):3070-7. PubMed ID: 14978112
[TBL] [Abstract][Full Text] [Related]
16. Endogenous antimicrobial peptides and skin infections in atopic dermatitis.
Ong PY; Ohtake T; Brandt C; Strickland I; Boguniewicz M; Ganz T; Gallo RL; Leung DY
N Engl J Med; 2002 Oct; 347(15):1151-60. PubMed ID: 12374875
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial host defense in the upper gastrointestinal tract.
Hosaka Y; Koslowski M; Nuding S; Wang G; Schlee M; Schäfer C; Saigenji K; Stange EF; Wehkamp J
Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1151-8. PubMed ID: 18989140
[TBL] [Abstract][Full Text] [Related]
18. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa.
Emelianov VU; Bechara FG; Gläser R; Langan EA; Taungjaruwinai WM; Schröder JM; Meyer KC; Paus R
Br J Dermatol; 2012 May; 166(5):1023-34. PubMed ID: 22136668
[TBL] [Abstract][Full Text] [Related]
19. New mechanisms of skin innate immunity: ASK1-mediated keratinocyte differentiation regulates the expression of beta-defensins, LL37, and TLR2.
Sayama K; Komatsuzawa H; Yamasaki K; Shirakata Y; Hanakawa Y; Ouhara K; Tokumaru S; Dai X; Tohyama M; Ten Dijke P; Sugai M; Ichijo H; Hashimoto K
Eur J Immunol; 2005 Jun; 35(6):1886-95. PubMed ID: 15864780
[TBL] [Abstract][Full Text] [Related]
20. Microbial symbiosis with the innate immune defense system of the skin.
Gallo RL; Nakatsuji T
J Invest Dermatol; 2011 Oct; 131(10):1974-80. PubMed ID: 21697881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
